Titre :
|
The next stage : Molecular epidemiology. Commentary. (1997)
|
Auteurs :
|
O. SHPILBERG ;
J.S. DORMAN ;
R.E. FERRELL ;
L.H. KULLER ;
A. SHAHAR ;
M. TRUCCO ;
Department of Epidemiology. Graduate School of Public Health. University of Pittsburgh. Pittsburgh Pennsylvania. USA
|
Type de document :
|
Article
|
Dans :
|
Journal of clinical epidemiology (vol. 50, n° 6, 1997)
|
Pagination :
|
633-638
|
Langues:
|
Anglais
|
Mots-clés :
|
Hérédité
;
Homme
;
Carcinogène
;
Médicament
;
Immunologie
;
Alimentation
;
Facteur risque
;
Prévention santé
;
Génétique
;
Epidémiologie
|
Résumé :
|
[BDSP. Notice produite par INIST G9DpR0xA. Diffusion soumise à autorisation]. The traditional approach in epidemiology of relating exposure to an environmental agent such as a drug or infective agent has been to measure an overall risk (i.e., average and then "adjust risk for demographic variables and other confounders"). An attempt is sometimes made to define a "susceptible" subgroup. The analyses are usually based on good statistical methodology rather than an understanding of the interaction of body of host and agent. A twofold risk for 1000 exposed versus nonexposed people could be an average twofold risk for all 1000 exposed or a 20-fold risk for 100 exposed individuals (i.e., a drug-host interaction). Clearly, finding the 100 individuals with a 20-fold risk has much greater clinical importance than a twofold risk for 1000 people. The world of epidemiology may be changing-we may soon he able to define risk based on genetic susceptibility, at least sometimes.
|